Precursor Conditions Unlock Potential for Early Interventions in Multiple Myeloma
March 29th 2022
Data presented at the ASH Annual Meeting and Exposition underscored the growing focus on improving screening, advancing methods of detection, and improving our understanding of the genomic, genetic, and epigenetic factors that govern progression and therapeutic resistance in multiple myeloma.